News

Condo building — with a Dunkin' — proposed for Brighton Center
A new building of condominiums — including three affordable units — has been proposed for Brighton Center. Biotech's Future - ...
The Pharma Letter3h
New data for nusinersen underscore Biogen’s commitment to SMA
US biotech major Biogen today announced new data that reinforce the clinical impact of nusinersen across a broad spectrum of ...
Biogen lauds benefits of higher dose Spinraza for spinal muscular atrophy
New data from Biogen reveals higher Spinraza doses may enhance motor function in SMA patients. Read more here.
Biogen Inc.: New Data for Nusinersen Underscore Biogen's Commitment to Advancing Clinical Research to Improve Outcomes in SMA
New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who transitioned to the investigational higher dose regimen of nusinersen from 12 mg SP ...
New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMA
New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who ...
STAT5h
Pharmalittle: We’re reading about the gray market for obesity meds, an RSV drug recommendation, and more
Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...
11 Most Undervalued US Stocks According To Analysts
He emphasized that residential investment will be crucial for overall GDP growth, as current CapEx spending in the US is ...